Bridget Huang is a seasoned researcher in vaccine R&D with extensive experience in biochemistry and molecular biophysics. They served as a Postdoctoral Research Scientist at Columbia University from 2017 to 2019, where they led projects on Hepatitis C Virus mechanisms. Prior to that, they were a Graduate Research Assistant at Columbia University Medical Center from 2010 to 2017, focusing on bacterial protein synthesis. Currently, Bridget holds a senior scientific position at Pfizer, where they lead vaccine antigen optimization and act as a subject matter expert in protein biochemistry and structural biology. They earned a Ph.D. from Columbia University in 2017 and a B.A. from Rutgers University in 2010.
This person is not in any teams
This person is not in any offices